Pomerantz LLP is investigating claims on behalf of investors of DXC Technology Company regarding potential securities fraud or unlawful business practices. The investigation follows DXC's May 7, 2026 financial results, which showed fourth-quarter revenue of approximately $3.13 billion, a 1.2% year-over-year decline and a 6.6% decline on an organic basis, with bookings down 13.5% year over year to approximately $3.3 billion. Management disclosed that the company missed its organic revenue guidance by approximately $75 million, or two percentage points, citing execution issues in addition to pipeline and demand challenges, and issued fiscal year 2027 guidance projecting continued organic revenue decline of approximately 3% to 5% year over year. On this news, DXC's stock price fell $2.58 per share, or 21.48%, to close at $9.43 per share on May 8, 2026.
DXC Technology CoRevenue decline, missed guidance, and bookings drop due to pipeline and demand challenges.